NCT04569461 Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) Status WITHDRAWN Phase PHASE2
NCT04565496 Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients Status WITHDRAWN Phase PHASE2
NCT04565457 A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality Status COMPLETED Phase NA
NCT04563936 Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® Status COMPLETED Phase PHASE3
NCT04560725 PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04560452 Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients Status COMPLETED Phase N/A
NCT04558866 Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04557501 PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04557449 Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04555343 Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention Status COMPLETED Phase PHASE1/PHASE2
NCT04552509 TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer Status RECRUITING Phase NA
NCT04550416 Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study Status COMPLETED Phase NA
NCT04549688 Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer Status RECRUITING Phase NA
NCT04545632 Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor Status COMPLETED Phase N/A